Abstract

Platelets play a key role in the physiological hemostasis or pathological process of thrombosis. Rhodocytin, an agonist of the C-type lectin-like receptor-2 (CLEC-2), elicits powerful platelet activation signals in conjunction with Src family kinases (SFKs), spleen tyrosine kinase (Syk), and phospholipase γ2 (PLCγ2). Previous reports have shown that rhodocytin-induced platelet aggregation depends on secondary mediators such as thromboxane A2 (TxA2) and ADP, which are agonists for G-protein-coupled receptors (GPCRs) on platelets. How the secondary mediators regulate CLEC-2-mediated platelet activation in terms of signaling is not clearly defined. In this study, we report that CLEC-2-induced Syk and PLCγ2 phosphorylation is potentiated by TxA2 and that TxA2 plays a critical role in the most proximal event of CLEC-2 signaling, i.e. the CLEC-2 receptor tyrosine phosphorylation. We show that the activation of other GPCRs, such as the ADP receptors and protease-activated receptors, can also potentiate CLEC-2 signaling. By using the specific Gq inhibitor, UBO-QIC, or Gq knock-out murine platelets, we demonstrate that Gq signaling, but not other G-proteins, is essential for GPCR-induced potentiation of Syk phosphorylation downstream of CLEC-2. We further elucidated the signaling downstream of Gq and identified an important role for the PLCβ-PKCα pathway, possibly regulating activation of SFKs, which are crucial for initiation of CLEC-2 signaling. Together, these results provide evidence for novel Gq-PLCβ-PKCα-mediated regulation of proximal CLEC-2 signaling by Gq-coupled receptors.

Highlights

  • Platelets play a key role in the physiological hemostasis or pathological process of thrombosis

  • We report that C-type lectin-like receptor-2 (CLEC-2)-induced spleen tyrosine kinase (Syk) and phospholipase ␥2 (PLC␥2) phosphorylation is potentiated by thromboxane A2 (TxA2) and that TxA2 plays a critical role in the most proximal event of CLEC-2 signaling, i.e. the CLEC-2 receptor tyrosine phosphorylation

  • We propose to investigate the mechanism of cross-talk between G-protein-coupled receptors and CLEC-2 during platelet activation induced by rhodocytin

Read more

Summary

Results

Non-aspirinated platelets respond more robustly to rhodocytin than aspirin-treated platelets. In Gq knock-out murine platelets, there was no Syk/PLC␥2 phosphorylation observed when stimulated with rhodocytin (5 nM) for 1 min as compared with wild types (Fig. 3F) Together, these results suggest that the Gq pathways downstream of different GPCRs play an essential role in regulating Syk phosphorylation upon CLEC-2 receptor activation. There is enhanced phosphorylation of SFKs by U46619 over control This phosphorylation is significantly inhibited in the presence of either UBO-QIC or GF109203X, suggesting that the Gq-PKC pathway downstream of GPCRs regulates the SFKs. to study the effect of enhanced SFK activation on the CLEC-2 tyrosine phosphorylation, we co-stimulated platelets with rhodocytin and U46619, and looked at the CLEC-2 tyrosine phosphorylation, which is mediated by SFKs. Fig. The activity of the inhibitor was tested using known controls (data not shown)

Discussion
Experimental procedures
Preparation of human platelets
Preparation of murine platelets
Platelet aggregation
Western blot analysis
Statistical analysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call